Literature DB >> 8954101

Crosslinking of SRF to the c-fos SRE CArG box guanines using photo-active thioguanine oligodeoxynucleotides.

M A Cahill1, A Nordheim, Y Z Xu.   

Abstract

6-Thioguanine (thioG) was chemically incorporated into 25-base oligodeoxynucleotides encoding the c-fos serum response element (SRE) at positions corresponding to each guanine of the CArG box, which only slightly impaired DNA binding by the Serum Response Factor (SRF). Upon exposure to long wavelength UV light each thioG-containing SRE could be crosslinked to SRF, with efficiencies ranging from < 1 to 25% of the complex depending on the position of thioG in the SRE and on the UV source used. Crosslinking was strongest to the 3' side of the CArG box, and to the outer rather than the inner CArG box guanines, consistent with hydrogen bonds formed between SRF and the outer guanines in the crystal structure [Pellegrini et al., Nature 376, 490, 1995]. The crosslinked product was found to be chemically unstable. Possible mechanisms of crosslink formation are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8954101     DOI: 10.1006/bbrc.1996.1775

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  DNA breakage and cell cycle checkpoint abrogation induced by a therapeutic thiopurine and UVA radiation.

Authors:  R Brem; F Li; B Montaner; O Reelfs; P Karran
Journal:  Oncogene       Date:  2010-05-03       Impact factor: 9.867

2.  Crosslinking of DNA repair and replication proteins to DNA in cells treated with 6-thioguanine and UVA.

Authors:  Quentin Gueranger; Azadeh Kia; David Frith; Peter Karran
Journal:  Nucleic Acids Res       Date:  2011-03-11       Impact factor: 16.971

3.  Photosensitized UVA-Induced Cross-Linking between Human DNA Repair and Replication Proteins and DNA Revealed by Proteomic Analysis.

Authors:  Melisa Guven; Karin Barnouin; Ambrosius P Snijders; Peter Karran
Journal:  J Proteome Res       Date:  2016-10-05       Impact factor: 4.466

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.